OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 1 CALL ON FILE

LSTA — Lisata Therapeutics, Inc.

NASDAQ

FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 6, 2025

REVENUE

$0 -100.0%

EPS

-$0.49 +9.3%

FREE CASH FLOW

-$3.3M +16.1%

No summary has been written for this call yet.